# Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

> **NCT03306901** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 240 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Esophagectomy
- **DRUG:** 5-fluorouracil
- **DRUG:** Cisplatin
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT03306901
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-10-20
- **Primary completion:** 2025-12-31
- **Final completion:** 2033-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03306901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03306901, "Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03306901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*